Zoetis Q1 revenue flat organic; cuts FY 2026 guidance on softer demand and competition

Zoetis Inc.

2026-Q1 EPS reported $1.42 revenue$2,262,000,000

Revenue $2.3B, +3% reported but flat organic; net income $601M ($1.42 EPS), flat YoY.
Adjusted net income $646M ($1.53 EPS), +2% reported, +1% organic; guidance cut: FY rev $9.68-9.96B (2-5% organic growth).
U.S. segment revenue down 8% on competitive pressure and macro price sensitivity; International up 10% organic.
Acquisition of Neogen animal genomics business announced March 2, expected to close H2 2026.
Pipeline includes >12 potential blockbusters; recent approvals in Canada, Thailand, Japan.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.